In many human cancers, the INK4A locus is frequently mutated by homozygous deletions. By alternative splicing this locus encodes two non-related tumor suppressor genes, p16
In many human cancers, the INK4A locus is frequently mutated by homozygous deletions. By alternative splicing this locus encodes two non-related tumor suppressor genes, p16
INK4A and p14 ARF (p19 ARF in mice), which regulate cell cycle and cell survival in the retinoblastoma protein (pRb) and p53 pathways, respectively. In mice, the role of p16
INK4A as the critical tumor suppressor gene at the INK4A locus was challenged when it was found that p19 ARF only knock-out mice developed tumors, including gliomas. We have analysed the genetic status of the INK4A locus in 105 primary gliomas using both microsatellite mapping (MSM) and quantitative realtime PCR (QRT ± PCR). Comparison of the results of the two methods revealed agreement in 67% of the tumors examined. In discordant cases,¯uorescence in situ hybridization (FISH) analysis was always found to support QRT ± PCR classi®cation. Direct assessment of p14 ARF exon 1b, p16 INK4A exon 1a and exon 2 by QRT ± PCR revealed 43 (41%) homozygous and eight (7%) hemizygous deletions at the INK4A locus. In 49 (47%) gliomas, both alleles were retained. In addition, QRT ±
Introduction
The INK4A locus consists of two overlapping genes that encode the two unrelated human proteins p16 INK4A and human p14 ARF (p19 ARF in mice), both mediating cell cycle arrest (Haber, 1997; Lloyd, 2000) . Exons 1a, 2 and 3 encode p16
INK4A which has been established as a tumor suppressor gene in human cancer (Cairns et al., 1995; Kamb et al., 1994; Nobori et al., 1994) . The alternative transcript p14 ARF is generated by alternative splicing of exon 1b (which lies approximately 20 kb upstream of exon 1a) onto exons 2 and 3 of INK4A, de®ning an entirely dierent reading frame (Duro et al., 1995; Mao et al., 1995; Quelle et al., 1995) . p16 INK4A induces G1 cell cycle arrest by inhibiting the phosphorylation of pRB by the cyclin-dependent kinases CDK4 and CDK6 (Serrano et al., 1993) . p14 ARF induces cell cycle arrest in a p53-dependent manner by binding to MDM2, resulting in the stabilization of p53 (Pomerantz et al., 1998; and in a p53-independent manner by either binding to MDM2 and blocking its inhibitory function of pRb (Carnero et al., 2000; Sun et al., 1998) or by directly regulating E2F-1 (Weber et al., 2000) . Therefore, simultaneous inactivation of both proteins would disrupt two critical cellular pathways which are involved in cell cycle regulation, senescence and apoptosis. In many human cancers, the INK4A locus is found to be inactivated predominantly by homozygous deletions which results in loss of function of both p16
INK4A and p14 ARF (Cairns et al., 1995; Jen et al., 1994) . In primary human tumor tissue, however, precise assessment of the genomic status of both INK4A products has been dicult due to technical limitations and the presence of non-neoplastic DNA (Cairns et al., 1994 (Cairns et al., , 1995 Hegi et al., 1997; Merlo et al., 1994) .
Two murine INK4A knock-out models have been established (Kamijo et al., 1997; Serrano et al., 1996) . In the ®rst model, most mice developed early growth of ®brosarcomas and lymphomas, con®rming the importance of this locus in mammalian tumorigenesis. In these animals, exons 2 and 3 of INK4A had been disrupted by homologous recombination, thus the animals lack both p16
INK4A and p19 ARF (Serrano et al., 1996) . Therefore, the question whether the murine cancer phenotype was induced by selective loss of (Kamijo et al., 1997; Serrano et al., 1996) . This raised the question of whether much of the phenotype ascribed to the p16 INK4A null-mice may in fact be attributed to disruption of p19 ARF . These ®ndings in mice raised the question as to whether p14 ARF alone is the tumor suppressor at the INK4A locus in human cancers. So far, experimental data supporting this view is scarce. The vast majority of human tumors appear to display large genomic deletions of the INK4A locus, homozygously deleting both alleles (Cairns et al., 1995) . 5' CpG island methylation as an alternative mechanism to inactivate the INK4A locus was found in a smaller fraction of tumors around exon 1a , whereas concomitant inactivation of p14 ARF and p16 INK4A by promoter methylation was rare (Robertson and Jones, 1998) . Moreover, point mutations only aecting the reading frame of one of the two gene products are also very rare and only target p16
INK4A (Cairns et al., 1995; Jen et al., 1994; Li et al., 1995) but not exon 1b of p14 ARF . Selective homozygous deletion of exon 1b was detected in three acute lymphoblastic leukemia (ALL) patients (Heyman et al., 1996) , in one sporadic melanoma patient (Glendening et al., 1995) , and in two melanoma cells lines (Kumar et al., 1998) . One malignant glioma xenograft has been described in which p14 ARF was selectively deleted (Jen et al., 1994) .
The rare detection of mutations that selectively target exon 1b of p14 ARF in human tumors could be caused by technical diculties inherent to the methods applied, such as multiplex PCR or MSM (Cairns et al., 1994 (Cairns et al., , 1995 Merlo et al., 1994) . To overcome these limitations we analysed 105 gliomas using QRT ± PCR and MSM. FISH was used to clarify ambiguous cases. INK4A may contribute to tumorigenesis in humans or that the mechanism causing homozygous deletions preferentially creates large deletions. Furthermore, we con®rmed that homozygous inactivation of the INK4A locus is a late event in tumor progression and showed that it is associated with poor survival rates in the glioblastoma subgroup of patients older than 50 years.
Results

Microsatellite mapping
To determine the frequency of hemi-and homozygous deletions at the INK4A locus in 105 gliomas, MSM was performed using 15 polymorphic (CA) n dinucleotide repeat markers extending across chromosome 9p21. Two of these polymorphic markers, D9S1748 and D9S942, separate exons 1a and 1b of the INK4A locus and were, therefore, important in identifying micro-deletions which targeted either p16 INK4A (Table 1) .
Quantitative real-time PCR
QRT ± PCR is well suited to identify micro-deletions within de®ned genetic loci. In contrast to MSM in which the genetic status of a speci®c locus such as INK4A requires information from¯anking regions, QRT ± PCR provides a direct and speci®c determination of the genetic status. To establish the sensitivity of the technique we initially diluted peripheral blood lymphocyte (PBL) DNA with DNA from the LN401 glioblastoma cell line at dierent ratios. The Ct values for GAPDH were the same for PBL and LN401 cell line DNA, demonstrating diploidy of the GAPDH locus in LN401. In undiluted PBL DNA, the copy (Figure 1 ). Equal dilution of PBL DNA with LN401 DNA reduced the copy number of both exons 1a and 1b by half relative to that of GAPDH, corresponding to a DCt value of 71 (Figure 1 ). Further dilution of PBL DNA to a point where pure LN401 DNA was analysed produced a linear dilution curve which reached a DCt value of 710. Analysis of exons 1a and 1b of the 105 tumors resulted in a distribution centered around the dilution line (Figures 1 and 2) . Furthermore, the genetic status of these tumors were distributed into three distinct groups centered at DCt values of 0 (DCt (E1a)=70.07+0.3; DCt (E1b)=0.1+0.2; mean+s.d., n=49; retention of both alleles), 71 (DCt (E1a)=71.0+0.16; DCt (E1b)=70.92+0.1; n=8; loss of one allele) and at 571.4 (DCt (E1a)=73.4+1.05; DCt (E1b)=72.45+0.88; n=43; loss of both alleles). The dierence between those groups centered at DCt=0 with DCt=71, and DCt=71 with DCt571.4 were found to be signi®-cantly dierent (U4U*, a=0.05; Mann ± Whitney test). An additional smaller group was also evident at DCt40.7 (DCt (E1a)=0.99+0.45; DCt (E1b)= 0.92+0.42; n=5) suggesting occasional hyperploidy of this locus in glioblastomas. In all 105 cases examined, the relative copy numbers of both exons 1a and 1b in individual tumors were the same, thus supporting MSM in which no selective deletion for either exon 1a or 1b was found.
We have also analysed the genetic status of exon 2 of the INK4A locus, which is common to both p16 INK4A and p14 ARF . Exon 2 contains the leader sequence for nucleolar localization of p14 ARF and is therefore crucial for complete activity of the protein (Zhang and Xiong, 1999) . In all cases the genetic status of exon 2 was equal to those of exons 1a and 1b (DCt=0.12+0.31; mean+s.d., n=49; retention of both alleles, DCt=70.86+0.27; n=8; loss of one allele, DCt (E2)=72.52+1.23; n=43; loss of both alleles, and DCt (E2)=0.81+0.55; n=5, hyperploidy) (data not shown).
A comparison of QRT ± PCR with MSM showed that deletion of the INK4A locus was highest in the most malignant form of glioma, GBM IV. However, in contrast to MSM, the detection of homozygous deletions was increased twofold by QRT ± PCR (Table  1) . Therefore, MSM clearly underestimated the true frequency of homozygous deletions targeting the INK4A locus.
Fluorescence in situ hybridization analysis FISH was employed to resolve the discrepancy between the results obtained by MSM and QRT ± PCR. Five tumors that had been classi®ed dierently according to MSM and QRT ± PCR and one tumor which was classi®ed as hemizygous deletion by both techniques were selected. In each case, the FISH classi®cation con®rmed QRT ± PCR data (Table 2) .
A striking feature of the tumor sections analysed by FISH is the variable heterogeneity of cells with respect to the alleleotype of the INK4A locus (Table 2) . Cells containing two copies of both alleles probably represent contaminating non-neoplastic material. However, it can not be excluded that some tumor cell clones have retained both copies of the INK4A locus, given that loss of the INK4A locus appears to be increasingly frequent in high-grade lesions (Table 1) . The classi®cation of homozygous deletions by MSM is indirect and might therefore be impaired by the presence of heterogeneous cell populations (Figures 2 and 3 and Table 2 ). In tumor BS13, MSM pointed to a hemizygous deletion whereas QRT ± PCR revealed a homozygous deletion. FISH analysis revealed that both alleles of the INK4A locus were absent in 83% of the nuclei, while 12% and 5% of the nuclei displayed either one or two copies of the INK4A locus, respectively (Table 2) . Surprisingly, even though the majority of nuclei were classi®ed as homozygously deleted for the INK4A locus, the low level of tumor heterogeneity was sucient to result in the two critical markers D9S942 and D9S1748 (Figure 3a ) being scored as hemizygous deletions. In contrast, direct ampli®ca-tion of exons 1a and 1b by QRT ± PCR, directly assessing the genes of interest, was suciently sensitive to overcome this problem.
Whereas tumor BS14 was a similar case as BS13 (Table 2 ) tumor BS6 was incorrectly classi®ed because no marker centromeric of the INK4A locus was informative. Tumors BS2, and BS24 were incorrectly classi®ed by MSM due to the failure to detect hemizygous losses¯anking the markers D9S1748 and D9S942 within the 9p21 region.
The INK4A locus predicts longer survival in elderly GBM IV patients To determine whether homozygous loss of sequences encoding p16 INK4A and p14 ARF at the INK4A locus was correlated with reduced survival of patients, the records of patients who had succumbed to GBM IV were examined. However, no signi®cant dierences were found in the survival times between patients with a homozygous deletion at the INK4A locus (n=29; mean survival rate=9.2 months) and those exhibiting retention of both copies of the INK4A locus (n=18; mean survival rate=12.9 months) (P=0.13, Anova test single factor, a=0.05). The only signi®cant dierence in patient survival, which correlated with the genetic status of the INK4A locus was seen in patients older than 50 years (homozygous deletion, mean survival rate=7.9 months, n=24; retention; mean survival rate=13.5 months, n=15) (P=0.025 Anova test single factor, a=0.05).
Discussion
In this study, QRT ± PCR allowed a precise and rapid genetic classi®cation of the INK4A locus in 105 human primary gliomas. QRT ± PCR was clearly superior to other PCR-based non-quantitative protocols in detecting small intragenic deletions and proved to be nearly twice as sensitive as the indirect microsatellite based approach in the detection of homozygous deletions (Cairns et al., 1994) . Comparison with FISH analysis showed that QRT ± PCR improved discrimination between DNA derived from tumor cells and contaminating non-neoplastic cells or neoplastic precursor cells not genetically altered at the locus of interest. This fact is exempli®ed in case BS13 (Figure 3b ) in which homozygously inactivated INK4A nuclei were counted in 83% of the cells. The residual 17% of cells harbored either one or two intact INK4A alleles which confounded MSM but not QRT ± PCR.
In this large series of patients, no case of a selective homozygous deletion of exon 1b was observed, an event we hypothesized to be detectable at a reasonable frequency given the compelling evidence from the selective murine p19
ARF knock-out model in which gliomas are observed in up to 10% of mice (Kamijo et al., 1999) . We found concomitant inactivation of both p16 INK4A and p14 ARF by a homozygous deletion to be the predominant type of genetic alteration at this locus in human gliomas, leading to simultaneous inactivation of two critical regulators of the p53 and the pRb pathways involved in the control of apoptosis and proliferative lifespan of cells (Lloyd, 2000) . In humans, both exons 1b and 2 of INK4A appear to be required for p14
ARF to be fully active (Zhang and Xiong, 1999) . This is in contrast to murine p19 ARF where exon 1b alone is sucient to induce cell cycle arrest Zhang et al., 1998) which might be due to a distinct leader sequence for nucleolar localization in murine p19 ARF (Zhang and Xiong, 1999) . Such dierences in the regulation of homologous genes between dierent species have to be considered for the construction of animal disease models. While some genes do have homologues in drosophila melanogaster and mice (e.g. p53 and pRb), homologues for p14 ARF and MDM2 have only been detected in mice but not in drosophila melanogaster (Rubin et al., 2000) .
Loss of both INK4A genes appears to be a mandatory step in the progression rather than initiation of many human gliomas, a view which is supported by the ®nding that the rates of homozygous deletions increase from low-grade to higher-grade lesions (Table 1) . However, the only signi®cant correlation between the genetic status at the INK4A locus and poorer survival rate was found in patients older than 50 years in the glioblastoma subgroup in this study which supports the ®ndings of a recent study (Newcomb et al., 1998) . The interpretation of gene expression at this locus as assessed by QRT ± PCR was complicated mainly by the presence of non-neoplastic cells. Nonetheless, lack of the p16 INK4A and preservation of the p14 ARF transcripts suggests gene silencing by promoter methylation in a few cases while high rates of p14 ARF transcription might be indicative for p53 mutations (Fulci et al., 2000; Stott et al., 1998) .
We conclude that QRT ± PCR is presently the most appropriate method to assess the genetic status of the INK4A locus in human primary tumor tissue and should be used in studies correlating molecular alterations with clinical data. In contrast to murine gliomas which arise in the selective p19 ARF knock-out animals, both INK4A gene products are frequently inactivated by homozygous deletions in human primary gliomas re¯ecting structural and/or functional phenomena.
Materials and methods
Tumors and cell lines
Tumor samples used in this study were obtained from 105 patients who underwent glioma resection at the University Hospitals of Basel, Lausanne and Geneva between 1996 and 1999. Tumors were classi®ed according to the revised WHO grading system (Kleihues et al., 1993) as 67 glioblastomas (grade IV), seven anaplastic astrocytomas (grade III), 10 astrocytomas (grade II), 11 oligodendrogliomas (grade II), three pilocytic astrocytomas (grade I), one mixed oligoastrocytoma (grade III), three mixed oligoastrocytomas (grade II), and three ependymomas. Microdissection, DNA and RNA extraction were performed as previously described (Maier et al., 1997 (Maier et al., , 1998 . Only DNA prepared from sections of brain tumor tissue which had less than 30% residual amounts of non-neoplastic cells following microdissection was used for analysis. The glioblastoma cell line LN401 which served as a control for a dilution experiment exhibits a homozygous deletion at the INK4A locus (Ishii et al., 1999) (Figure 1 ).
Microsatellite mapping
DNA from 47 glial tumor specimens and PBL was analysed for loss of heterozygosity by ampli®cation of dinucleotide repeat-containing sequences (Maier et al., 1997) . Primers for these sequences were obtained from Research Genetics (Huntsville, AL, USA) and Microsynth (Switzerland). For informative cases, allelic loss was scored if the radiographic signal of one allele was at least 50% less in tumor DNA as compared to the corresponding normal allele. In addition, uorescence based MSM was employed with DNA from all 105 gliomas . Six polymorphic (CA) nrepeat markers around the INK4A locus (IFNa, D9S1749, D9S2136, D9S942, D9S1748 and D9S171) were labeled with one of the¯uorescent dyes 6'FAM, HEX or TET. PCR products were separated and analysed on the ABI PRISM 310 GeneScan System (PE Biosystems, Forster City, CA, USA). The ratio of peak heights of both alleles were calculated for each tumor and PBL DNA. respectively, are shown. Tumor BS13 was mapped as a hemizygous deletion at the INK4A locus, indicated by the two markers D9S942 and D9S1748. Open circles denote retention of both alleles, black circles denote loss of one allele, hatched circles were not informative. Right: Whereas markers D9S2136 (ratio 0.987) and D9S171 (ratio 1.074) showed the same ratio between allele 1 and allele 2 (grey) in PBL (N) and tumor (T) DNA, indicating a retention of both alleles, the two markers D9S942 (ratio 2.528) and D9S1748 (ratio 2.234) showed a ratio of more than 1.5 between lymph DNA and tumor DNA, indicating a loss of the smaller allele (hemizygous deletion) at these markers. (b) FISH analysis in BS13 revealed 83% of the cells to harbour a homozygous deletion at INK4A. Grey: centromere 9 probe. White: 9p21 probe (arrow)
PBL DNA was more than 1.5 (1/0) or less than 0.66 (0/2). Homozygous deletions were scored if a marker at the INK4A locus shows a small retention surrounded by markers displaying large hemizygous deletions (Cairns et al., 1995) .
Quantitative real time-PCR
Classi®cation of the genetic status of exons 1a, 1b and 2 was performed on the TaqMan ABI PRISM 7700 Sequence Detection System (PE Biosystems, CA, USA) using gene speci®c primers for GAPDH, which is located on chromosome 12p13.3, exon 1b (E1b), exon 1a (E1a) and exon 2 (E2). Primers for GAPDH ampli®cation were 5'-AATGGGACT-GAGGCTCCAC (sense) and 5'-TTATGGGAAAGCCAGT-CCCC (antisense), for E1b 5'-TGATGCTACTGAGGAGC-CAGC (sense) and 5'-AGGGCCTTTCCTACCTGGTC (antisense), for E1a 5'-CCCAACGCACCGAATAGTTAC and 5'-ATTCCAATTCCCCTGCAAACT (antisense) and for E2 5'-CCACCCTGGCTCTGACCAT (sense) and 5'-GCCACTCGGGCGCTG (antisense). Gene speci®c¯uores-cent oligomeric probes were GAPDH 5'-ATCCAAGACTG-GCTCCTCCCTGCTG (sense), E1b 5'-TCTAGGGCAGCA-GCCGCTTCCTAGA (sense), E1a 5'-CCACCTGGATCG-GCCTCCGG (antisense) and E2 5'-TGTTCTCTCTGGCA-GGTCATGATGATGG (sense). PCR conditions, primers and probe design was assessed by the Primer Expression program (PE Biosystems). Final primer concentration was 200 nM and¯uorescent oligomeric probe concentration was 50 nM. Fifty ng genomic DNA derived from primary tumor tissue was taken as template. All analyses of tumor samples were performed in triplets in parallel with PBL DNA. In this approach the variable C t is de®ned as the fractional cycle number at which the¯uorescence generated by cleavage of the probe by the exonucleolytic activity of the polymerase crosses a ®xed threshold. Dierences in the C t values between two genes is referred to DC t value. After normalization of the tumor C t values with the PBL C t values, the DC t values and the relative copy number of exons 1a, 1b and 2 were calculated as follows: DC t (X)=C t (reference)7C t (X).
Fluorescence in situ hybridization analysis FISH analysis was performed using the¯uorescein-labeled cosmid clone C1 (40 kb) containing the entire INK4A gene as a probe (kindly provided by D Sidransky, Johns Hopkins Hosptial, Baltimore, MD, USA). A rhodamine centromere probe for chromosome 9 (pMR9a) (Rocchi et al., 1991) was separately denatured and mixed with the cosmid probe prior to hybridization. Touch preparations from frozen tumor material were made on glass slides and used for FISH analysis as previously described (Gortz et al., 1999; Speel et al., 1997) . Hybridization signals were scored using a Zeiss Axiophot Fluorescence microscope and tri-color images were captured using the Vysis Quips Genetic Workstation (IG Instrumenten-Gesellschaft, Bern, Switzerland). At least 100 interphase cell nuclei with strong hybridization signals were scored for each tumor. If 30% of the nuclei exhibited no or only one INK4A signal the tumor was interpreted as harboring a homozygous (double allelic) or a hemizygous (single allelic) deletion, respectively (Zhuang et al., 1997) . Normal control samples (lymphocytes, adult brain) exhibited two INK4A signals in 495% of the nuclei.
